Главная Назад


Авторизация
Идентификатор пользователя / читателя
Пароль (для удалённых пользователей)
 

Вид поиска

Область поиска
в найденном
Найдено в других БД
Формат представления найденных документов:
библиографическое описание краткийполный
Отсортировать найденные документы по:
авторузаглавиюгоду изданиятипу документа
Поисковый запрос: (<.>A=Khazaeli, M. B.$<.>)
Общее количество найденных документов : 27
Показаны документы с 1 по 20
 1-20    21-27 
1.
Zhou Y.G. {9}{0}Y-Labeled 17-1А Monoclonal Antibody Prepared Using The New Bifunctional Chelating Agent DOTA-NHS // J. Labell. Compounds and Radiopharm., 1994. Vol. 35.-С.318-319

2.
Phase I clinical and pharmacological study of suppression of human antimouse antibody response to monoclonal antibody L6 by deoxyspergualin // Cancer Res., 1995. Vol. 55, N 14.-С.3060-3067

3.
Approaches to enhance cancer radioterapy employing gene transfer methods // Gene Ther., 1996. Vol. 3, N 12.-С.1042-1068

4.
Approaches to enhance cancer radioterapy employing gene transfer methods // Gene Ther., 1996. Vol. 3, N 12.-С.1042-1068

5.
Approaches to enhance cancer radioterapy employing gene transfer methods // Gene Ther., 1996. Vol. 3, N 12.-С.1042-1068

6.
Production of a single chain anti-CEA antibody from the hybridoma cell line T84.66 using a modified colony-lift selection procedure to detect antigen-positive ScFv bacterial clones // Hybridoma, 1998. Vol. 17, N 1.-С.1-8

7.
Idiotypic vaccination with a murine anti-dsDNA antibody. Phase I study in patients with nonactive systemic lupus erythematosus with nephritis // J. Rheumatol., 1999. Vol. 26, N 12.-С.2602-2608

8.
Idiotypic vaccination with a murine anti-dsDNA antibody. Phase I study in patients with nonactive systemic lupus erythematosus with nephritis // J. Rheumatol., 1999. Vol. 26, N 12.-С.2602-2608

9.
Idiotypic vaccination with a murine anti-dsDNA antibody. Phase I study in patients with nonactive systemic lupus erythematosus with nephritis // J. Rheumatol., 1999. Vol. 26, N 12.-С.2602-2608

10.
Impact of patient-specific mass on liver dosimetry for radioimmunotherapy // J. Nucl. Med., 2002. Vol. 43, N 5 прил..-С.86P

11.
Impact of patient-specific mass on liver dosimetry for radioimmunotherapy // J. Nucl. Med., 2002. Vol. 43, N 5 прил..-С.86P

12.
Initial clinical experience with CC49 pretarget radioimmunotherapy using a new genetically engineered fusion protein // J. Nucl. Med., 2002. Vol. 43, N 5 прил..-С.314

13.
Initial clinical experience with CC49 pretarget radioimmunotherapy using a new genetically engineered fusion protein // J. Nucl. Med., 2002. Vol. 43, N 5 прил..-С.314

14.
Phase Phase I trial of multiple large doses of murine monoclonal antibody CO17-1А I: Clinical aspects // J. Nat. Cancer Inst., 1988. Vol. 80, N 12.-С.932-936

15.
Phase I trial of multiple large doses of murine monoclonal antibody CO17-1А II: Pharmacokinetics and immune response // J. Nat. Cancer Inst., 1988. Vol. 80, N 12.-С.937-942

16.
Shaw Denise R. Mouse/human chimeric antibodies to a tumor-associated antigen: Biologic activity of the four human IgG subclasses // J. Nat. Cancer Inst., 1988. Vol. 80, N 19.-С.1553-1559

17.
Khazaeli M.B. Quantitative assay of a human monoclonal IgM antibody (НА-1А) in human serum // J. Immunol. Meth., 1989. Vol. 117, N 2.-С.175-180

18.
Khazaeli M.B. Quantitative assay of a human monoclonal IgM antibody (HA-1А) in human serum // J. Immunol. Meth., 1989. Vol. 117, N 2.-С.175-180

19.
Khazaeli M.B. Quantitation of mouse monoclonal antibody and human anti-mouse antibody response in serum of patients // Hybridoma, 1989. Vol. 8, N 2.-С.231-239

20.
Khazaeli M.B. Quantitative assay of a human monoclonal IgM antibody (НА-1А) in human serum // J. Immunol. Meth., 1989. Vol. 117, N 2.-С.175-180

 1-20    21-27 
 




© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)